Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Annals of Hematology|September 17, 2024
Only FLT3-ITD co-mutation did not have a deleterious effect on acute myeloid leukemia patients with NPM1 mutation, but concomitant with DNMT3A co-mutation or a < 3log reduction of MRD2 predicted poor survivalWenbing Duan, Jinsong Jia, Jing Wang, et al.British Journal of Haematology|February 25, 2020
Detection of measurable residual disease may better predict outcomes than mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPAJing Wang, RunQing Lu, Ying Wu, et al.Cancers|August 14, 2025
IKZF1 Variants Predicted Poor Outcomes in Acute Myeloid Leukemia Patients with CEBPA bZIP In-Frame MutationsShunjie Yu, Lijuan Hu, Yazhen Qin, et al.The Oncologist|August 19, 2025
Prognostic covariates associated with outcomes in patients with NPM1-mutated acute myeloid leukemiaShunjie Yu, Sen Yang, Lijuan Hu, et al.Annals of Hematology|February 18, 2025
Genetic abnormalities predict outcomes in patients with core binding factor acute myeloid leukemiaShunjie Yu, Sen Yang, Lijuan Hu, et al.Acta Haematologica|October 21, 2025
Discrepancies in Treatment Goals and Concerns Regarding Disease Management between Patients with Myeloproliferative Neoplasms and Hematologists in China: Analysis from a Multicenter Cross-Sectional SurveyJunling Zhuang, Hongxia Shi, Xiaoli Liu, et al.Leukemia & Lymphoma|June 8, 2021
Variables associated with patient-reported outcomes in patients with myeloproliferative neoplasmsDayu Shi, Hongxia Shi, Xiaoli Liu, et al.Acta Haematologica|February 22, 2023
Patient-Reported Outcomes in Young Adults with Myeloproliferative NeoplasmsMei Bao, Mengyu Zhang, Hongxia Shi, et al.Pageof 5